TAIHO PHARMACEUTICAL Overview
Upcoming Projects (TAIHO PHARMACEUTICAL)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (TAIHO PHARMACEUTICAL)
-
A look at the Phase 2b REZILIENT1 trial evaluating Taiho Pharmaceutical's zipalertinib in patients with EGFR Exon 20 insertion mutation–positive non-small cell lung cancer.
Tickers: TAIHO PHARMACEUTICAL, CGEM
Executed On: Jun 12, 2025 at 11:30 AM EDT
Upcoming & Overdue Catalysts (TAIHO PHARMACEUTICAL)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (TAIHO PHARMACEUTICAL)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
